Systematic review / meta-analysis 2021
Original English research record

Prognostic properties of hypoalbuminemia in COVID-19 patients: A systematic review and diagnostic meta-analysis.

Clinical nutrition ESPEN

Original abstract

Abstract

Background Coronavirus disease 2019 (COVID-19) elicits robust inflammatory reaction that may result in a declining albumin serum level. This meta-analysis aimed to evaluate the prognostic properties of hypoalbuminemia for poor prognosis and factors that may influence the relationship.

Method A systematic literature search of PubMed was conducted from inception to April 22, 2021. The main exposure was albumin level below normal range-defined by the included studies. The outcome of interest was composite poor outcome that comprises of mortality, severity, and the requirement of mechanical ventilation or intensive care unit.

Results There were 6200 patients from 19 studies. Meta-analysis showed that hypoalbuminemia was associated with composite poor outcome (OR 6.97 (95% CI 4.20-11.55), p 2 = 91.3%, p 2 = 69.6%, p 2 = 92.5%, p

Conclusion Hypoalbuminemia was associated with poor prognosis in COVID-19 patients.

Authors and publication

Soetedjo NNM, Iryaningrum MR, Damara FA, Permadhi I, Sutanto LB, Hartono H, Rasyid H.

Journal
Clinical nutrition ESPEN
Publication year
2021
DOI
10.1016/j.clnesp.2021.07.003
Open the full source
This abstract is for information and research. It is not medical advice, a diagnosis or a treatment recommendation.